VFA
LKFT

Valeo Financial Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Valeo Financial Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4
Closed -$1K – 1797
2020
Q2 		$1K Buy
+4
New +$828 ﹤0.01% 1879

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Valeo Financial Advisors's LKFT Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 4 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in LKFT in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 4 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $1K.
  • Valeo Financial Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2020 and held it in 1 quarter.
  • Valeo Financial Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $1K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.